MAPK8 and acute promyelocytic leukemia: Mechanistically, the activation of JNK (c-jun NH2 terminal kinase), a molecular gefitinib off-target (36), plays a crucial role in the ATO-induced apoptosis of APL cells (37), partially explaining the mild cytotoxicity antagonism interaction between ATO and gefitinib.